Association between cannabis use and risk of metabolic disease in UK biobank
- 17 April 2026
- journal article
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 36 (9) , 104762
Abstract
No abstract availableKeywords
Funding Information
- Key Research and Development Program of Zhejiang Province
This publication has 32 references indexed in Scilit:
- Global, regional, and national trends in metabolic risk factor-associated mortality among the working-age population from 1990-2019: An age-period-cohort analysis of the Global Burden of Disease 2019 studyMetabolism, 2024
- Genetic Insights into the causal relationship between cannabis use and diabetic phenotypes: A genetic correlation and Mendelian randomization studyDrug and Alcohol Dependence, 2023
- Association between metabolic syndrome and risk of incident dementia in UK BiobankAlzheimer's & Dementia, 2023
- Association between cannabis use and risk of diabetes mellitus type 2: A systematic review and meta‐analysisPhytotherapy Research, 2023
- Cannabis Use Disorder and Subsequent Risk of Psychotic and Nonpsychotic Unipolar Depression and Bipolar DisorderJAMA Psychiatry, 2023
- Association of Healthy Lifestyle Factors and Obesity-Related Diseases in Adults in the UKJAMA Network Open, 2023
- The global burden of metabolic disease: Data from 2000 to 2019Cell Metabolism, 2023
- Association between cannabis use and ten-year estimated atherosclerotic cardiovascular disease risk in a middle-aged population surveyEuropean Journal of Internal Medicine, 2023
- Effects of cannabis use on body mass, fasting glucose and lipids during the first 12 months of treatment in schizophrenia spectrum disordersSchizophrenia Research, 2018
- Public health and international drug policyThe Lancet, 2016